Neil Gunn

Non-Executive Director / Genetic Signatures

Dr Neil Gunn has over 30 years of medical device and diagnostics experience from managing operations in Europe and the USA. He has knowledge of the diagnostic market, global product development, clinical, quality and regulatory processes, strategy development and commercial operations.

Dr Gunn was president of Roche Sequencing Solutions, a business unit of Roche Diagnostics, and vice president of its Molecular Diagnostic business unit prior to that. During this twelve-year tenure, he was responsible for over 120 diagnostic product launches (Instruments, assays, Software) with a principle focus on IVD clinical markets.

Lists and Charts

Roles

2021

Non-Executive Director

Genetic Signatures

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
365^th	Toubani Resources	38.46%	0%
366^th	US Masters Residential Property Fund	38.26%	-13.57%
367^th	Genetic Signatures	38.23%	-8.88%
368^th	Westfield Innaloo	38.02%	21.57%
369^th	Westfield Whitford City	38.02%	21.57%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Non-Executive Director, Genetic Signatures

13 Apr 2021

Related Information

Access to our data for Neil Gunn is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Neil Gunn is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.